In a larger double-blind clinical trial, participants on once-weekly semaglutide injections lost an average of 15% of their baseline body weight over 68 weeks
Once you know the big pharmaceutical companies are spending a lot of money looking for glucagon receptor antagonists and testing them, and GIP receptor antagonists and testing them, it requires a lot of gusto, a lot of lunacy and craziness to say, nah, I believe all these big pharmaceutical companies are wrong, my lab is doing the opposite. But now, the sentiment has drastically shifted and many companies are looking to co-agonist drugs to achieve over 20%, or even close to 30% weight loss
And accountability when those standards are not met
The total investment for a single drug application can range from $80 million to $1.2 billion, with an overall development timeline of approximately 8-12 years
The tablets are manufactured by a reputable supplier and have been tested for safety and efficacy
InjectCo Fort Worth follows a nurse-led model where licensed RNs and nurse practitioners provide care under appropriate medical supervision and within Texas Medical Board guidelines